Ji-Won Kim
Chief Executive Officer bij AJU IB INVESTMENT CO., LTD.
Profiel
Ji-Won Kim is currently the Chief Executive Officer of Aju IB Investment Co., Ltd.
(Private Equity) and also holds the position of Director at SL VaxiGen, Inc. Prior to this, he was the Chief Executive Officer & Director at AJU IB Investment Co., Ltd.
starting from 1999.
Mr. Kim completed his undergraduate degree from Yonsei University.
Actieve functies van Ji-Won Kim
Bedrijven | Functie | Begin |
---|---|---|
AJU IB INVESTMENT CO., LTD. | Chief Executive Officer | 01-01-1999 |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea. | Chief Executive Officer | - |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology SL VaxiGen, Inc. operates as research and development company which engages in developing vaccine therapeutics based on complementary platforms for saving lives. The company was founded on March 3, 2017 and is headquartered in Seongnam, South Korea. | Director/Board Member | - |
Opleiding van Ji-Won Kim
Yonsei University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AJU IB INVESTMENT CO., LTD. | Finance |
Bedrijven in privébezit | 2 |
---|---|
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea. | Finance |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology SL VaxiGen, Inc. operates as research and development company which engages in developing vaccine therapeutics based on complementary platforms for saving lives. The company was founded on March 3, 2017 and is headquartered in Seongnam, South Korea. | Health Technology |